Niacin Skin Flush Response in Patients With Schizophrenia
NCT02458924 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2015-06-02
Summary
Patients with schizophrenia have abnormal skin flush response to niacin, but the niacin skin test accuracy is not well studied in these patients. The study evaluated the niacin skin test accuracy in adult hospitalized schizophrenia patients and their first degree relatives, bipolar disorder patients, and healthy controls.
Conditions
Interventions
- BIOLOGICAL
-
Niacin skin test
Two concentrations including 0.5 ml solutions of 0.01 M and 0.1 M diluted methyl nicotinate were applied for one minute to the inside of the different forearms of each individual.
Sponsors & Collaborators
-
Isfahan University of Medical Sciences
lead OTHER
Principal Investigators
-
Maryam Tabatabaeian, MD · Isfahan University of Medical Sciences
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
More Related Trials
-
Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics
NCT01246128 ·Status: WITHDRAWN
-
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
NCT01339858 ·Status: COMPLETED ·Phase: PHASE4
-
Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia
NCT01506765 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
NCT00063297 ·Status: COMPLETED ·Phase: PHASE2
-
Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia
NCT00376233 ·Status: COMPLETED
-
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
NCT00942981 ·Status: COMPLETED
-
Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
NCT00061789 ·Status: COMPLETED ·Phase: PHASE2
-
Knowledge and Perception of Smoking Risks/Consequences
NCT00686101 ·Status: COMPLETED
-
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder
NCT00382915 ·Status: COMPLETED
-
Clinical Trial of AVL-3288 in Schizophrenia Patients
NCT02978599 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Nicotine on Cognition in Schizophrenia
NCT00383747 ·Status: COMPLETED ·Phase: PHASE4
-
N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis
NCT01354132 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
NCT01213524 ·Status: COMPLETED ·Phase: PHASE2
-
Inflammatory Response In Schizophrenia
NCT03093064 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia
NCT00373126 ·Status: COMPLETED ·Phase: PHASE4
-
Once Weekly D-cycloserine for Schizophrenia
NCT00964041 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia
NCT03838484 ·Status: TERMINATED ·Phase: NA
-
Sulforaphane to Reduce Symptoms of Schizophrenia
NCT02810964 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
NCT00135772 ·Status: COMPLETED
-
Examining Persistence in Smokers With Schizophrenia
NCT03346291 ·Status: COMPLETED ·Phase: NA
-
Trial of D-Cycloserine in Schizophrenia
NCT00000371 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of D-serine in Schizophrenia
NCT00322023 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia
NCT04510298 ·Status: COMPLETED ·Phase: PHASE1
-
Cigarette Smoking in Smokers With and Without Schizophrenia
NCT04001114 ·Status: COMPLETED ·Phase: NA
-
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
NCT02505477 ·Status: COMPLETED ·Phase: PHASE4